Vulnerability Description
Changjetong T+ versions up to and including 16.x contain a .NET deserialization vulnerability in an AjaxPro endpoint that can lead to remote code execution. A remote attacker can send a crafted request to /tplus/ajaxpro/Ufida.T.CodeBehind._PriorityLevel,App_Code.ashx?method=GetStoreWarehouseByStore with a malicious JSON body that leverages deserialization of attacker-controlled .NET types to invoke arbitrary methods such as System.Diagnostics.Process.Start. This can result in execution of arbitrary commands in the context of the T+ application service account. Exploitation evidence was observed by the Shadowserver Foundation as early as 2023-08-19 (UTC).
CVSS Score
CRITICAL
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Chanjetvip | T\+ | <= 16.000.000.0283 |
Related Weaknesses (CWE)
References
- https://blog.csdn.net/qq_53003652/article/details/134031230ExploitThird Party Advisory
- https://blog.csdn.net/u010025272/article/details/131553591ExploitThird Party Advisory
- https://github.com/MD-SEC/MDPOCS/blob/main/ChangJieTongTPlus_GetStoreWarehouseByProduct
- https://www.chanjetvip.com/product/goods/detail?id=6077e91b70fa071069139f62Release Notes
- https://www.freebuf.com/articles/web/381731.htmlExploitThird Party Advisory
- https://www.vulncheck.com/advisories/changjetong-tplus-getstorewarehousebystore-Third Party Advisory
- https://www.freebuf.com/articles/web/381731.htmlExploitThird Party Advisory
FAQ
What is CVE-2023-7334?
CVE-2023-7334 is a vulnerability with a CVSS score of 9.8 (CRITICAL). Changjetong T+ versions up to and including 16.x contain a .NET deserialization vulnerability in an AjaxPro endpoint that can lead to remote code execution. A remote attacker can send a crafted reques...
How severe is CVE-2023-7334?
CVE-2023-7334 has been rated CRITICAL with a CVSS base score of 9.8/10. This is considered a critical vulnerability requiring immediate attention.
Is there a patch for CVE-2023-7334?
Check the references section above for vendor advisories and patch information. Affected products include: Chanjetvip T\+.